0HV Stock Overview Develops, manufactures, markets, and sells dental products in the United States, China, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Envista Holdings Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Envista Holdings Historical stock prices Current Share Price US$19.20 52 Week High US$21.56 52 Week Low US$17.30 Beta 1.31 1 Month Change n/a 3 Month Change n/a 1 Year Change n/a 3 Year Change -50.69% 5 Year Change -26.15% Change since IPO -28.89%
Recent News & Updates
Envista Holdings Corporation Reaffirms Earnings Guidance for the Full Year 2024 Nov 02
Envista Holdings Corporation to Report Q3, 2024 Results on Oct 30, 2024 Oct 08 Envista Holdings Corporation Announces Chief Financial Officer Changes
Envista Holdings Corporation to Report Q2, 2024 Results on Aug 07, 2024 Jul 13
Envista Holdings Corporation Announces Step Down of Eric Conley as Senior Vice President and President, Orthodontics, Effective June 3, 2024 Jun 02
First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.27 in 1Q 2023) May 04 See more updates
Envista Holdings Corporation Reaffirms Earnings Guidance for the Full Year 2024 Nov 02
Envista Holdings Corporation to Report Q3, 2024 Results on Oct 30, 2024 Oct 08 Envista Holdings Corporation Announces Chief Financial Officer Changes
Envista Holdings Corporation to Report Q2, 2024 Results on Aug 07, 2024 Jul 13
Envista Holdings Corporation Announces Step Down of Eric Conley as Senior Vice President and President, Orthodontics, Effective June 3, 2024 Jun 02
First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.27 in 1Q 2023) May 04 Envista Holdings Corporation Announces Chief Executive Officer Changes
Envista Holdings Corporation, Annual General Meeting, May 21, 2024 Apr 09
Envista Holdings Corporation to Report Q1, 2024 Results on May 01, 2024 Apr 05
Insufficient new directors Mar 14
Full year 2023 earnings released: US$0.60 loss per share (vs US$1.46 profit in FY 2022) Feb 17
Insufficient new directors Feb 15
Envista Holdings Corporation Provides Earnings Guidance for the Full Year 2024 Feb 08
Envista Holdings Corporation to Report Q4, 2023 Results on Feb 07, 2024 Jan 12
Envista Holdings Corporation Appoints Three New Members to Leadership Team Dec 15
Insufficient new directors Dec 02
New minor risk - Shareholder dilution Nov 03
Third quarter 2023 earnings released: EPS: US$0.13 (vs US$0.30 in 3Q 2022) Nov 02
Envista Holdings Corporation Provides Earnings Guidance for the Year 2023 Nov 02
Envista Holdings Corporation to Report Q3, 2023 Results on Nov 01, 2023 Oct 06
Insufficient new directors Sep 25
Envista Holdings Corporation to Report Q2, 2023 Results on Aug 02, 2023 Jul 07
Insufficient new directors May 31
Investor sentiment deteriorates as stock falls 16% May 31
Envista Holdings Corporation Provides Earnings Guidance for the Year 2023 Feb 09
Envista Holdings Corporation to Report Q4, 2022 Results on Feb 08, 2023 Jan 13
Envista Holdings Corporation Provides Earnings Guidance for the Year 2022 Nov 04
Envista Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022 Oct 05
High number of new directors Sep 29
Second quarter 2022 earnings released: EPS: US$0.27 (vs US$0.49 in 2Q 2021) Aug 05
Envista Holdings Corporation Provides Sales Guidance for 2022 Aug 05
Envista Holdings Corporation Provides Sales Guidance for 2022 Aug 04
Envista Holdings Corporation to Report Q2, 2022 Results on Aug 03, 2022 Jul 14
Investor sentiment deteriorated over the past week Jun 20
Envista Holdings Corporation (NYSE : NVST) agreed to acquire Osteogenics Biomedical, Inc., Allotech, LLC and OBI Biologics, Inc. May 18
First quarter 2022 earnings released: EPS: US$0.43 (vs US$0.39 in 1Q 2021) May 06 Envista Holdings Corporation Provides Unaudited Consolidated Impairment Charges for the First Quarter Ended April 1, 2022
High number of new and inexperienced directors Apr 27
Envista Holdings Corporation (NYSE:NVST) completed the acquisition of Scanning Technology business of Carestream Dental LLC from Carestream Dental Parent Limited. Apr 21 Envista Holdings Corporation to Report Q1, 2022 Results on May 04, 2022
Envista Holdings Corporation Announces Executive Changes Apr 01
Envista Holdings Corporation Obtains FDA Clearance for Assisted Intelligence Mandibular Nerve Tracing Mar 29
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 10
Investor sentiment improved over the past week Dec 28
Envista Holdings Corporation Receives FDA 510(k) Clearance for the Nobel Biocare N1™ Implant System Dec 28
Envista Holdings Corporation (NYSE:NVST) entered into an agreement to acquire Scanning Technology business of Carestream Dental LLC for $600 million. Dec 23
Third quarter 2021 earnings released: EPS US$0.50 (vs US$0.22 in 3Q 2020) Nov 04
planmeca Verwaltungs GmbH entered into a binding agreement to acquire KaVo Dental Treatment Unit and Instrument Business for approximately $460 million. Sep 08
Second quarter 2021 earnings released: EPS US$0.56 (vs US$0.59 loss in 2Q 2020) Aug 04
First quarter 2021 earnings released: EPS US$0.45 (vs US$0.11 loss in 1Q 2020) May 07
New 90-day high: €33.20 Mar 13
Insider recently sold €411k worth of stock Feb 20
Envista Extends Partnership with Heartland Dental to Continue Providing Innovative Dental Solutions to Its Vast Network of Supported Doctors Feb 18
Full year 2020 earnings released: EPS US$0.21 (vs US$1.60 in FY 2019) Feb 13
Revenue beats expectations Feb 13
New 90-day high: €31.80 Feb 07
Envista Holdings Corporation to Report Q4, 2020 Results on Feb 10, 2021 Jan 27
New 90-day high: €30.40 Jan 14
New 90-day high: €26.80 Dec 28
New 90-day high: €25.80 Dec 05
New 90-day high: €24.80 Nov 11
Third-quarter earnings released: Revenue beats expectations Oct 31
Third quarter earnings released Oct 31
Envista Holdings Corporation to Report Q3, 2020 Results on Oct 29, 2020 Oct 15
Envista Holdings Corporation Is Not Providing Guidance for 2020 Aug 17
New 90-day high - €20.80 Aug 15
Envista Holdings Corporation to Report Q2, 2020 Results on Jul 30, 2020 Jul 22
Envista Holdings Corporation(NYSE:NVST) dropped from Russell 2500 Growth Index Jul 03
Envista Holdings Corporation(NYSE:NVST) dropped from Russell 3000 Growth Index Jul 02 Shareholder Returns 0HV DE Medical Equipment DE Market 7D 0% -2.9% -2.6% 1Y n/a -8.5% 6.9%
See full shareholder returns
Return vs Market: Insufficient data to determine how 0HV performed against the German Market .
Price Volatility Is 0HV's price volatile compared to industry and market? 0HV volatility 0HV Average Weekly Movement n/a Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 0HV's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 0HV's volatility change over the past year.
About the Company Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Show more Envista Holdings Corporation Fundamentals Summary How do Envista Holdings's earnings and revenue compare to its market cap? 0HV fundamental statistics Market cap €3.08b Earnings (TTM ) -€1.28b Revenue (TTM ) €2.40b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0HV income statement (TTM ) Revenue US$2.50b Cost of Revenue US$1.15b Gross Profit US$1.36b Other Expenses US$2.69b Earnings -US$1.34b
Last Reported Earnings
Sep 27, 2024
Earnings per share (EPS) -7.77 Gross Margin 54.20% Net Profit Margin -53.42% Debt/Equity Ratio 46.3%
How did 0HV perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 01:15 End of Day Share Price 2024/12/13 00:00 Earnings 2024/09/27 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Envista Holdings Corporation is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null Baird Jeffrey Johnson Baird Michael Cherny BofA Global Research
Show 19 more analysts 
